Related Experiment Video

Updated: Sep 1, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

AIDS related opportunistic infections, going but not gone

Rafik Samuel1, Robert L Bettiker, Byungse Suh

  • 1Section of Infectious Diseases, Temple University Hospital, Philadelphia, Pennsylvania 19140, USA. rafiksamuel@hotmail.com

Archives of Pharmacal Research
|July 24, 2002
PubMed

Insights

The AIDS epidemic has seen major advances in diagnosing, preventing, and treating opportunistic infections like PCP, Toxoplasma, CMV, MAC, and Cryptococcus. These improvements have significantly reduced AIDS-related infections in North America and Western Europe.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • The Acquired Immunodeficiency Syndrome (AIDS) epidemic emerged over 20 years ago, initially marked by Pneumocystis carinii pneumonia (PCP).
  • HIV infection predisposes individuals to various opportunistic infections, including Toxoplasma gondii, Cytomegalovirus (CMV), Mycobacterium avium complex (MAC), and Cryptococcus neoformans.
  • These infections significantly impact individuals with compromised immune systems due to HIV.

Purpose of the Study:

  • To review common opportunistic infections associated with HIV/AIDS.
  • To highlight advancements in the diagnosis, prevention, and treatment of these infections.
  • To discuss the impact of these advancements on infection rates in specific geographic regions.

Main Methods:

  • Literature review of opportunistic infections in HIV/AIDS patients.
  • Analysis of trends in diagnosis, prevention, and treatment strategies.
  • Examination of epidemiological data on infection rates.

Main Results:

  • Significant improvements in diagnostic tools, preventative measures, and therapeutic interventions for opportunistic infections.
  • Substantial decrease in the incidence of opportunistic infections secondary to AIDS in North America and Western Europe.
  • Identification of key pathogens including PCP, Toxoplasma gondii, CMV, MAC, and Cryptococcus neoformans.

Conclusions:

  • Advances in medical science have dramatically improved outcomes for individuals with HIV-associated opportunistic infections.
  • The decline in opportunistic infection rates signifies the success of public health initiatives and medical treatments.
  • Continued research and vigilance are essential for managing opportunistic infections in the context of HIV/AIDS.

More Related Videos

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...